bioMérieux has received CE Mark certifications for all of its in vitro diagnostic (IVD) products currently marketed in the European Union (EU). In compliance with the requirements of the 98/79/EC directive for CE Marking, which became applicable on December 7th, 2003, these certifications enable bioMérieux to continue to sell its products within the European Union after this date.
Cepheid and bioMérieux enter into strategic commercial program
06 January, 2004
bioMerieux to Apply Cepheid Platform Technology to NASBA Amplification Technology.